New COVID booster shows promise in 887-person trial

NCT ID NCT05142553

First seen Mar 22, 2026 · Last updated May 23, 2026 · Updated 1 time

Summary

This study tested a new booster vaccine called PHH-1V in 887 adults who had already received two doses of the Pfizer COVID-19 vaccine. The goal was to see if PHH-1V could safely boost immunity as well as or better than another Pfizer dose. The trial also looked at giving a fourth dose of PHH-1V to some participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clinic de Barcelona

    Barcelona, Barcelona, 17170, Spain

  • Hospital Clínico de Valencia

    Valencia, Valencia, 46010, Spain

  • Hospital Germans Trias I Pujol

    Badalona, BARCELONA, 08916, Spain

  • Hospital Gregorio Marañón

    Madrid, Madrid, 28007, Spain

  • Hospital Principe de Asturias

    Meco, Madrid, 28805, Spain

  • Hospital Regional Universitario de Málaga

    Málaga, Málaga, 29010, Spain

  • Hospital Universitari Dr. Josep Trueta

    Girona, Girona, 17007, Spain

  • Hospital Universitario La Paz

    Madrid, Madrid, 28046, Spain

  • Hospital Vall Hebron

    Barcelona, BARCELONA, 08035, Spain

  • Hospital de Cruces

    Barakaldo, VIZCAYA, 48903, Spain

Conditions

Explore the condition pages connected to this study.